Search
for
Sort by
Research 931–960 of 1000+
- The PDGF/PDGFR pathway as a drug target
- Historical and Current Adenosine Receptor Agonists in Preclinical and Clinical Development
- <i>Eclipta prostrata</i> promotes the induction of anagen, sustains the anagen phase through regulation of FGF-7 and FGF-5
- BRIDGING THE GAP IN ACNE MANAGEMENT: A NARRATIVE REVIEW OF CURRENT THERAPIES AND THE EMERGENCE OF CLASCOTERONE
- Testosterone Treatment in Women – An Overview
- Dermatological drugs, topical agents, and cosmetics
- Hormone Blocking Anticancer Drugs
- Reporting on Adverse Clinical Events
- Pharmacologic Modulation of Sebaceous Gland Activity: Mechanisms and Clinical Applications
- ODAC Chairs Reveal Challenges, High Drama in a Decade of Service
- Low-Molecular-Weight Synthetic Antioxidants: Classification, Pharmacological Profile, Effectiveness and Trends
- Alopecia Areata and Atopic Dermatitis: Common Mechanisms and Emerging Therapeutics
- Pharmacovigilance-based drug repurposing: searching for putative drugs with hypohidrosis or anhidrosis adverse events for use against hyperhidrosis
- Management of hypotrichosis of the eyelashes: Focus on bimatoprost
- Off‐Label Use of Topical Ruxolitinib in Dermatology: A Systematic Literature Review and Current Perspectives
- Ponatinib-induced pityriasis rubra pilaris-like adnexal dysmaturation: A case report
- Promotion of Hair Regrowth in Androgenetic Alopecia with Supplemented Erzhi Wan: Exploring Its Mechanism Using Network Pharmacology and Molecular Docking
- JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology
- From mechanisms to therapies: current advances breakthroughs in alopecia areata immunopathology
- A review on computer‐aided chemogenomics and drug repositioning for rationalCOVID‐19 drug discovery
- Targeted radionuclide therapy for head and neck squamous cell carcinoma: a review
- Real-world safety of Tepotinib: Insights from the Food and Drug Administration Adverse Event Reporting System
- Systemic Absorption and Pharmacokinetics of Five Novel Topical Dermatologic Agents: A Review
- The Off-Label Use of Selective Serotonin Reuptake Inhibitors for Sexual Behavior Management: Risks and Considerations
- Safety of Common Medications for Treating Dermatology Disorders in Pregnant Women
- Progress in studies of epidermal stem cells and their application in skin tissue engineering
- Nanocarriers as Active Ingredients Enhancers in the Cosmetic Industry—The European and North America Regulation Challenges
- Effectiveness of Extracellular Vesicle Application in Skin Aging Treatment and Regeneration: Do We Have Enough Evidence from Clinical Trials?
- Clinical Management of Prostate Cancer in High-Risk Genetic Mutation Carriers
- Natural bioactive compounds as potential sources for alleviation and treatment of androgenetic alopecia: A research advance